Besifloxacin Hydrochloride: Advanced Ophthalmic Antibiotic for Bacterial Conjunctivitis Treatment
A powerful fluoroquinolone antibiotic designed to combat bacterial eye infections with advanced delivery technology.
Get a Quote & SampleProduct Core Value
Besifloxacin Hydrochloride
Besifloxacin Hydrochloride is a cutting-edge, fourth-generation fluoroquinolone antibiotic specifically formulated for ophthalmic use. It is clinically proven to treat bacterial conjunctivitis, often referred to as pink eye, in patients as young as one year old. The active antibacterial molecule works by effectively killing the infectious bacteria responsible for the infection. Leveraging DuraSite® technology, this ophthalmic suspension ensures prolonged contact time on the eye's surface, providing sustained antibacterial action for up to 12 hours and offering a flexible dosing schedule that fits patient lifestyles. This makes it an essential component in managing ocular infections effectively and comfortably.
- Discover effective treatment for bacterial conjunctivitis with Besifloxacin Hydrochloride, a key solution for managing common eye infections.
- Experience the advanced delivery of Besifloxacin Hydrochloride thanks to DuraSite® technology, ensuring extended protection against ocular pathogens.
- Learn about the flexible dosing of Besifloxacin Hydrochloride, designed to accommodate various patient needs while maintaining efficacy.
- Explore the mechanism of action of Besifloxacin Hydrochloride, which targets and eliminates bacteria by inhibiting crucial DNA synthesis enzymes.
Advantages
Potent Antibacterial Action
This fluoroquinolone antibiotic demonstrates potent, broad-spectrum activity against a wide range of bacteria, crucial for combating drug-resistant pathogens and treating bacterial conjunctivitis.
Extended Ocular Coverage
The integration of DuraSite® technology ensures the active ingredient, besifloxacin, remains on the eye's surface for up to 12 hours, providing consistent protection and reducing the frequency of application.
Patient-Centric Dosing
With a flexible dosing regimen of 3 times a day, 4 to 12 hours apart, this product offers convenience for patients, including children, while ensuring effective treatment of eye infections.
Key Applications
Bacterial Conjunctivitis Treatment
The primary application is the effective treatment of bacterial conjunctivitis, commonly known as pink eye, caused by susceptible bacteria. This helps restore eye health swiftly.
Ophthalmic Antibacterial Use
Serves as a vital ophthalmic antibacterial medicine, offering a reliable solution for various eye infections where bacterial presence is confirmed.
Pediatric Ocular Care
The product is approved for use in children as young as one year of age, making it a safe and effective option for pediatric ocular infections.
Long-Term Eye Health Management
Its extended coverage technology assists in managing chronic or recurring ocular bacterial issues, contributing to better long-term eye health outcomes.